Billy Evans, partner of Elizabeth Holmes, is reportedly raising funds for a healthcare startup named Haemanthus, which claims to test blood and biomarkers in seconds. This venture echoes the notorious fraud of Theranos, leading to inevitable comparisons. Evans' project seeks to first cater to pet health before expanding to human health. It's notable that promotional materials for Haemanthus show prototypes that closely resemble Theranos's failed blood-testing devices, raising questions about innovation versus imitation in the health tech arena.
A photo provided to potential investors of the start-up's prototype bears more than a passing physical resemblance to Theranos's infamous blood-testing machine.
In a matter of seconds, the marketing material said Mr. Evans's machine would be able to identify and qualify biomarkers such as glucose and hormones.
Collection
[
|
...
]